Risk factors for infections after endoscopic retrograde cholangiopancreatography (ERCP): a retrospective cohort analysis of US Medicare Fee-For-Service claims, 2015-2021
- PMID: 36691191
- PMCID: PMC9472111
- DOI: 10.1136/bmjopen-2022-065077
Risk factors for infections after endoscopic retrograde cholangiopancreatography (ERCP): a retrospective cohort analysis of US Medicare Fee-For-Service claims, 2015-2021
Abstract
Objective: Contaminated reprocessed duodenoscopes pose a serious threat to patients in the endoscopy unit. Despite manufacturer changes to reprocessing guidelines, 20% of reprocessed duodenoscopes meet criteria for quarantine-level contamination based on microbiological or ATP testing. We aimed to examine risk factors for postendoscopic retrograde cholangiopancreatography (ERCP) infection.
Design: Retrospective cohort analysis.
Setting: US Medicare Fee-For-Service claims (2015-2021) and all-payer data (2017).
Participants: In the Medicare data, 823 575 ERCP procedures were included. The all-payer five-state data, 16 609 procedures were included.
Interventions: ERCP was identified by Current Procedural Terminology and International Classification of Disease (ICD) procedure codes. We identified inpatient infections using ICD diagnosis codes.
Outcome measures: A logistic regression model predicted risk factors for infections occurring within 7-day and 30-day periods following ERCP. 7-day and 30-day all-cause hospitalisations and post-ERCP pancreatitis were also examined.
Results: Post-ERCP infection occurred within 3.5% of 7-day and 7.7% of 30-day periods in Medicare. Disposable duodenoscopes were billed in 711 procedures, with 1.4% (n=10, 7-day) and 3.5% (n=25, 30-day) post-ERCP infections. Urgent ERCPs were the strongest risk factor for infections in the 7-day period (OR 3.3, 95% CI 3.2 to 3.4). Chronic conditions, sex (male), age (older) and race (non-white) were also risk factors. In the all-payer five-state data, fewer infections (2.4%, 7 days) were observed. No difference arose between Medicare and other payers for 7-day period infections (OR 1.0, 95% CI 0.7 to 1.3).
Conclusions: Urgent ERCPs, patient chronic conditions and patient demographics are post-ERCP infection risk factors. Patients with infection risk factors should be targeted for specialised infection control prevention measures, including disposable duodenoscopes.
Keywords: ERCP; Medicare; duodenoscope; endoscopy; health services research; infection.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: SH has received unrestricted research funding from Medivators, Inc. No other authors have disclosures.
Figures
Similar articles
-
Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography.Clin Gastroenterol Hepatol. 2020 Aug;18(9):2108-2117.e3. doi: 10.1016/j.cgh.2019.10.052. Epub 2019 Nov 6. Clin Gastroenterol Hepatol. 2020. PMID: 31706060
-
Infection control in ERCP using a duodenoscope with a disposable cap (ICECAP): rationale for and design of a randomized controlled trial.BMC Gastroenterol. 2020 Mar 12;20(1):64. doi: 10.1186/s12876-020-01200-7. BMC Gastroenterol. 2020. PMID: 32164535 Free PMC article.
-
Effect of Disposable Elevator Cap Duodenoscopes on Persistent Microbial Contamination and Technical Performance of Endoscopic Retrograde Cholangiopancreatography: The ICECAP Randomized Clinical Trial.JAMA Intern Med. 2023 Mar 1;183(3):191-200. doi: 10.1001/jamainternmed.2022.6394. JAMA Intern Med. 2023. PMID: 36689215 Free PMC article.
-
Duodenoscope-associated infections: a review.Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2205-2213. doi: 10.1007/s10096-019-03671-3. Epub 2019 Sep 3. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31482418 Review.
-
Device profile of the EXALT Model D single-use duodenoscope for endoscopic retrograde cholangiopancreatography: overview of its safety and efficacy.Expert Rev Med Devices. 2021 May;18(5):421-427. doi: 10.1080/17434440.2021.1917990. Epub 2021 Apr 23. Expert Rev Med Devices. 2021. PMID: 33855920 Review.
Cited by
-
Effect of a novel endoscope cleaning brush on duodenoscope contamination.Endoscopy. 2024 Mar;56(3):198-204. doi: 10.1055/a-2193-4481. Epub 2023 Oct 17. Endoscopy. 2024. PMID: 37848074 Free PMC article.
-
Carbapenem-resistant Enterobacterales sepsis following endoscopic retrograde cholangiopancreatography: risk factors for 30-day all-cause mortality and the development of a nomogram based on a retrospective cohort.Antimicrob Resist Infect Control. 2024 Aug 7;13(1):84. doi: 10.1186/s13756-024-01441-1. Antimicrob Resist Infect Control. 2024. PMID: 39113089 Free PMC article.
-
The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in Italy.Glob Reg Health Technol Assess. 2024 Dec 31;11:258-264. doi: 10.33393/grhta.2024.3186. eCollection 2024 Jan-Dec. Glob Reg Health Technol Assess. 2024. PMID: 39822274 Free PMC article.
References
-
- United States food and drug administration. infections associated with Reprocessed Duodenoscopes, 2019. Available: https://www.fda.gov/medical-devices/reprocessing-reusable-medical-device... [Accessed 9 July 2021].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources